SCHEMBL29367303

SCHEMBL29367303

O=C1CCC(N2C(=O)c3cc(C4CCNCC4)ccc3C2O)C(=O)N1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 15/20 0.42
▸ DDB1 Q16531 10/20 0.42
▸ IKZF3 Q9UKT9 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ OPRM1 P35372 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ IKZF2 Q9UKS7 4/20 0.39
▸ TNF P01375 1/20 0.38
▸ IL1B P01584 1/20 0.38
▸ TBXA2R P21731 1/20 0.38
▸ IKZF1 Q13422 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22291652 1.00 CRBN (0.42) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22291636 0.91 CRBN (0.44) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL29370547 0.91 CRBN (0.44) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24132551 0.84 CRBN (0.39) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL24046480 0.82 IKZF1 (0.38) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL22873398 0.82 CRBN (0.54) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL20233810 0.82 CRBN (0.62) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL23986383 0.81 CRBN (0.46) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL25469933 0.81 CRBN (0.46) CRBNDDB1IKZF3ALDH1A1CHRM2
SCHEMBL21208002 0.81 CRBN (0.60) CRBNDDB1IKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116322780-A Compounds and uses thereof 福宏治疗公司 2023-06-23 — — CN disclosed
EP-4188447-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2023-06-07 — — EP disclosed
WO-2022025880-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2022-02-03 — — WO disclosed
Send feedback